'Platelet reactivity' presentation slideshows

La terapia medica nel dislipidemico con SCA: dalle statine agli antiaggreganti

690 views • 46 slides

Causal Effects in Integrative Genomics

Causal Effects in Integrative Genomics. Carlo Berzuini and Brian Tom MRC Biostatistics Unit, Cambridge. Collaboration with Alison Goodall and Chris Jones, Department of Cardiovascular Sciences, University of Leicester Cambridge, December 2006. Aim.

424 views • 42 slides

Hidden Menace -Stent Thrombosis in Drug Eluting Stent Era

746 views • 40 slides

Bringing Platelet Function in From the Cold: Platelet Response Redux

Bringing Platelet Function in From the Cold: Platelet Response Redux. ARCTIC: Treatment of Poor Responders . ARCTIC: Primary & Secondary End Points. Events Rates Low in Stable PCI. POPULAR: Event Rate by Platelet Reactivity. ARCTIC: Subgroups. ARCTIC: Bleeding End Points.

471 views • 26 slides

Dietmar Trenk, PhD On behalf of the TRIGGER-PCI Investigators

Primary Results of T esting platelet R eactivity I n patients under G oing elective stent placement on clopidogrel to G uide alternative th E rapy with p R asugrel TRIGGER-PCI Study. TCT 2011. Dietmar Trenk, PhD On behalf of the TRIGGER-PCI Investigators. Disclosures.

411 views • 23 slides

Literature Review

Literature Review. Peter R. McNally, DO, FACP, FACG University Colorado Denver School of Medicine Center for Human Simulation Aurora, Colorado 80045. Gilard M 1 , Arnaud B 2 , Cornily JC 1 , Le Gal G 3 , Lacut K 3 , Le Calvez G 2 , Mansourati J 1 , Mottier D 2 , Abgrall JF 2 , Boschat J 1.

293 views • 21 slides

Gurbel PA, Bliden KP, DiChiara J, Bassi A, Herzog WR, Gesheff TB, Tantry US

Bivalirudin With and Without Eptifibatide for Elective Stenting: A Pharmacodynamic Study of Platelet Reactivity in Relation to the Occurrence of Periprocedural Myocardial Infarction (The CLEAR PLATELETS-2 Study). Gurbel PA, Bliden KP, DiChiara J, Bassi A, Herzog WR, Gesheff TB, Tantry US

314 views • 20 slides

Platelet activity in patients with patent vs. occluded bypass grafts. Prague-4 study subanalysis

Platelet activity in patients with patent vs. occluded bypass grafts. Prague-4 study subanalysis. P. Osman cik 1 , F. Bednar 2 , H. M o cikov a 3 , P. S tros 1 , K. Jirasek 2 , Z. Straka 2 , P. Widimsk y 1 1. Cardiocenter, Department of Cardiology, 3rd Medical School, Charles University

249 views • 16 slides

Background

Effect of Aspirin Dose on Platelet Reactivity in Diabetic Patients Paul A. Gurbel, MD Director, Sinai Center for Thrombosis Research Sinai Hospital of Baltimore Associate Professor of Medicine Johns Hopkins University School of Medicine Baltimore, MD. Background.

290 views • 15 slides

Objective

Objective. To determine whether nonresponsiveness to clopidogrel as revealed by high in vitro residual platelet reactivity after a 600 mg loading of the drug is predictive of drug-eluting stent thrombosis and cardiac mortality at long-term follow-up. Background.

276 views • 14 slides

Bliden et al. JACC. 2007 Feb 13; 49 (6): 657-66.

Increased Risk in Patients with High Platelet Aggregation Receiving Chronic Clopidogrel Therapy Undergoing Percutaneous Coronary Intervention: Is the Current Antiplatelet Therapy Adequate?.

247 views • 11 slides

Bliden et al. JACC. 2007 Feb 13; 49 (6): 657-66.

Increased Risk in Patients with High Platelet Aggregation Receiving Chronic Clopidogrel Therapy Undergoing Percutaneous Coronary Intervention: Is the Current Antiplatelet Therapy Adequate?.

225 views • 11 slides

Francesco Franchi, MD, Fabiana Rollini, MD, Jose Rivas Rios, MD, Andrea Rivas, MD,

Francesco Franchi, MD, Fabiana Rollini, MD, Jose Rivas Rios, MD, Andrea Rivas, MD, Malhar Agarwal, MD, Megha Kureti, MD, Deepa Nagaraju, MD, Mustafa Wali , MD,

128 views • 11 slides